Source library for EU AI Act.
verified anchorsRegulation (EU) 2024/1689
2024-07-12 · Primary source for articles, definitions, annexes, obligations, and application dates.
European Commission AI Act policy page
Current · Commission implementation context, timeline framing, and policy explanation.
AI literacy questions and answers
Current · Commission-facing practical Q&A for Article 4 AI literacy expectations.
AI Act implementation timeline
Current · Application milestones and phased implementation context for public tracking.
What can be used publicly and what must stay bounded.
public-safeOfficial source first
Use regulator, source-owner, EUR-Lex, FDA, EMA, ICH, ISO/IEC, ISPE, IMDRF, Health Canada, MHRA or similar authority/source-owner pages before commentary.
Paid-source boundary
Where a standard or guide is protected, the page names the source and describes public-safe implications without reproducing protected clause text.
Status visible
Every source needs date/status language so draft, final, watch item, and effective/applicable dates are not mixed.
Interpretation separated
Source fact and iFeed interpretation must remain visibly separated before any checklist is published.
Objects that deserve stable child pages.
future expansionArticle 3 definitions
Use for terms such as AI system, provider, deployer, importer, distributor, authorised representative, GPAI model, and serious incident.
Article 4 AI literacy
Creates a practical training and competence evidence layer for providers and deployers from 2025-02-02.
Article 5 prohibited practices
Early applicability gate; relevant before deeper classification work because some uses are not allowed.
Article 6 and Annex III high-risk classification
Classification depends on intended purpose, role, EU nexus, and listed high-risk areas.
Articles 8-15 high-risk system controls
Risk management, data governance, technical documentation, record keeping, transparency, human oversight, accuracy, robustness, and cybersecurity.
Article 26 deployer obligations
Important for life-sciences and healthcare organisations using third-party systems.
Article 50 transparency duties
Separate from high-risk status; user-facing disclosure may still apply.
Articles 61-72 post-market and incident chain
Turns deployment into an ongoing evidence and reporting workflow.